DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway(2023)

期刊：Discover Oncology

DOI：10.1007/s12672-023-00762-8

影響因子：2.2

引用產品： BT-549 細胞, MCF 10A 細胞, MDA-MB-231 細胞, SK-BR-3 [SKBR3] 細胞, MCF7 [MCF-7] 細胞

FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo(2023)

期刊：Molecular & Cellular Toxicology

DOI：10.1007/s13273-023-00368-9

影響因子：1.7

引用產品： MCF 10A 細胞, DMEM/F12 培養(yǎng)基, 馬血清, 青霉素-鏈霉素溶液 (雙抗)，100×, MDA-MB-231 細胞, MDA-MB-468 細胞, DMEM高糖 培養(yǎng)基, BT-549 細胞, RPMI-1640 培養(yǎng)基, MDA-MB-436 細胞

Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting(2023)

期刊：CELLULAR AND MOLECULAR BIOLOGY

DOI：10.14715/cmb/2023.69.8.12

影響因子：1.6

引用產品： MDA-MB-231 細胞, BT-549 細胞, MDA-MB-468 細胞, MCF7 [MCF-7] 細胞

Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription(2022)

期刊：Journal Of Experimental & Clinical Cancer Research

DOI：10.1186/s13046-022-02260-1

影響因子：11.300

引用產品： Hs 578T 細胞, BT-549 細胞, HCT-15 細胞, MCF 10A 細胞, A549 [A-549] 細胞, SK-OV-3 細胞, Hela 細胞, PANC-1 細胞

Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer(2022)

期刊：ONCOLOGY RESEARCH

DOI：10.32604/or.2022.026616

影響因子：4.938

引用產品： BT-549/ADR 細胞, MCF-7/ADR 細胞, SK-BR-3 [SKBR3] 細胞, MDA-MB-468-06 細胞, BT-549 細胞, MCF7 [MCF-7] 細胞

The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway(2022)

期刊：TOXICOLOGY AND APPLIED PHARMACOLOGY

DOI：10.1016/j.taap.2022.116232

影響因子：4.500

引用產品： T-47D 細胞, Hs 578T 細胞, MCF7 [MCF-7] 細胞, BT-20 細胞, BT-549 細胞, MCF 10A 細胞, RPMI-1640 培養(yǎng)基, MEM 培養(yǎng)基, DMEM/F12 培養(yǎng)基

p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target(2022)

期刊：MOLECULAR BIOLOGY REPORTS

DOI：10.1007/s11033-022-08047-z

影響因子：2.700

引用產品： BT-549 細胞

Hsa_circ_0069094 positively regulates the expression of oncogenic ZNF217 by competitively targeting miR-758–3p to promote the development of breast cancer(2022)

期刊：Reproductive Biology

DOI：10.1016/j.repbio.2022.100708

影響因子：2.100

引用產品： MDA-MB-231 細胞, BT-549 細胞, MCF 10A 細胞, Leibovitz's L-15 培養(yǎng)基, RPMI-1640 培養(yǎng)基, DMEM高糖 培養(yǎng)基

Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021)

期刊：Cell Death & Disease

DOI：10.1038/s41419-021-03684-x

影響因子：9.000

引用產品： MDA-MB-231 細胞, MDA-MB-468 細胞, MDA-MB-453 細胞, BT-549 細胞, MCF 10A 細胞, MCF7 [MCF-7] 細胞, BT-474 [BT474] 細胞

MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021)

期刊：Cell Death & Disease

DOI：10.1038/s41419-021-03661-4

影響因子：9.000

引用產品： MDA-MB-157 細胞, Hs 578T 細胞, BT-549 細胞, MDA-MB-231 細胞, MDA-MB-468 細胞, MCF 10A 細胞, 293T [HEK-293T] 細胞, DMEM/F12完全培養(yǎng)基 (含10%FBS)